Literature DB >> 22713584

Number and brightness analysis of LRRK2 oligomerization in live cells.

Nicholas G James1, Michelle A Digman, Enrico Gratton, Barbara Barylko, Xiaodong Ding, Joseph P Albanesi, Matthew S Goldberg, David M Jameson.   

Abstract

Leucine-rich repeat kinase 2 (LRRK2) is a large multidomain protein that contains enzymatically functional GTPase and kinase domains. Several noncoding LRRK2 gene polymorphisms have been associated with susceptibility to Parkinson's disease (PD), Crohn's disease, and leprosy. Many LRRK2 coding polymorphisms have been associated with or causally linked to PD. The G2019S point mutation within the LRRK2 kinase domain is the most common cause of familial PD. The G2019S mutation appears to alter LRRK2 kinase activity. Some but not all studies have reported that LRRK2 kinase activity is dependent upon LRRK2 dimerization and membrane localization. It is important to define the oligomeric state(s) of LRRK2 in living cells, which to date have only been characterized in vitro. Here we use confocal and total internal reflection microscopy coupled with number and brightness analysis to study the oligomeric states of LRRK2 within the cytosol and on the plasma membrane of live CHO-K1 cells. Our results show, for the first time to our knowledge, that LRRK2 is predominantly monomeric throughout the cytosol of living cells, but attains predominately higher oligomeric states in the plasma membrane.
Copyright © 2012 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22713584      PMCID: PMC3368136          DOI: 10.1016/j.bpj.2012.04.046

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  17 in total

1.  Protein kinases linked to the pathogenesis of Parkinson's disease.

Authors:  Jie Shen
Journal:  Neuron       Date:  2004-11-18       Impact factor: 17.173

2.  Oligomerization state of dynamin 2 in cell membranes using TIRF and number and brightness analysis.

Authors:  Justin A Ross; Michelle A Digman; Lei Wang; Enrico Gratton; Joseph P Albanesi; David M Jameson
Journal:  Biophys J       Date:  2011-02-02       Impact factor: 4.033

3.  Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity.

Authors:  Andrew B West; Darren J Moore; Catherine Choi; Shaida A Andrabi; Xiaojie Li; Dustin Dikeman; Saskia Biskup; Zhenshui Zhang; Kah-Leong Lim; Valina L Dawson; Ted M Dawson
Journal:  Hum Mol Genet       Date:  2007-01-02       Impact factor: 6.150

4.  Re-examination of the dimerization state of leucine-rich repeat kinase 2: predominance of the monomeric form.

Authors:  Genta Ito; Takeshi Iwatsubo
Journal:  Biochem J       Date:  2012-02-01       Impact factor: 3.857

5.  Kinase activity of mutant LRRK2 mediates neuronal toxicity.

Authors:  Wanli W Smith; Zhong Pei; Haibing Jiang; Valina L Dawson; Ted M Dawson; Christopher A Ross
Journal:  Nat Neurosci       Date:  2006-09-17       Impact factor: 24.884

6.  Fluorescence fluctuation spectroscopy: ushering in a new age of enlightenment for cellular dynamics.

Authors:  David M Jameson; Justin A Ross; Joseph P Albanesi
Journal:  Biophys Rev       Date:  2009-09-01

7.  Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation.

Authors:  Zdenek Berger; Kelsey A Smith; Matthew J Lavoie
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

8.  The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity.

Authors:  Luxuan Guo; Payal N Gandhi; Wen Wang; Robert B Petersen; Amy L Wilson-Delfosse; Shu G Chen
Journal:  Exp Cell Res       Date:  2007-07-19       Impact factor: 3.905

9.  The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation.

Authors:  Elisa Greggio; Ibardo Zambrano; Alice Kaganovich; Alexandra Beilina; Jean-Marc Taymans; Veronique Daniëls; Patrick Lewis; Shushant Jain; Jinhui Ding; Ali Syed; Kelly J Thomas; Veerle Baekelandt; Mark R Cookson
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

10.  The WD40 domain is required for LRRK2 neurotoxicity.

Authors:  Nathan D Jorgensen; Yong Peng; Cherry C-Y Ho; Hardy J Rideout; Donald Petrey; Peng Liu; William T Dauer
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

View more
  27 in total

1.  Metabolic imaging in multiple time scales.

Authors:  V Krishnan Ramanujan
Journal:  Methods       Date:  2013-09-04       Impact factor: 3.608

2.  Medical school hotline: the research mission of the cell and molecular biology department and program at the john a. Burns school of medicine.

Authors:  Marla J Berry; Joshua Astern; Frederick Bellinger; Christopher Brampton; Rebecca Cann; Mariana Gerschenson; David Haymer; Nicholas G James; David M Jameson; Olivier LeSaux; Peter R Hoffmann; Robert Nichols; Matthew Pitts; Lucia Seale; Steven Seifried; Alexander J Stokes; Cedomir Todorovic
Journal:  Hawaii J Med Public Health       Date:  2015-04

3.  FISIK: Framework for the Inference of In Situ Interaction Kinetics from Single-Molecule Imaging Data.

Authors:  Luciana R de Oliveira; Khuloud Jaqaman
Journal:  Biophys J       Date:  2019-08-06       Impact factor: 4.033

4.  Measuring protein dynamics in live cells: protocols and practical considerations for fluorescence fluctuation microscopy.

Authors:  Robert T Youker; Haibing Teng
Journal:  J Biomed Opt       Date:  2014-09       Impact factor: 3.170

5.  Quantitative Brightness Analysis of Protein Oligomerization in the Nuclear Envelope.

Authors:  Jared Hennen; Kwang-Ho Hur; Cosmo A Saunders; G W Gant Luxton; Joachim D Mueller
Journal:  Biophys J       Date:  2017-07-11       Impact factor: 4.033

Review 6.  Scanning number and brightness yields absolute protein concentrations in live cells: a crucial parameter controlling functional bio-molecular interaction networks.

Authors:  Christina Papini; Catherine A Royer
Journal:  Biophys Rev       Date:  2018-01-30

7.  Synthesis and In Vitro and In Vivo Evaluation of [3H]LRRK2-IN-1 as a Novel Radioligand for LRRK2.

Authors:  Noeen Malik; Andrew N Gifford; Johan Sandell; Daniel Tuchman; Yu-Shin Ding
Journal:  Mol Imaging Biol       Date:  2017-12       Impact factor: 3.488

8.  Phosphatidylserine Lateral Organization Influences the Interaction of Influenza Virus Matrix Protein 1 with Lipid Membranes.

Authors:  Sara Bobone; Malte Hilsch; Julian Storm; Valentin Dunsing; Andreas Herrmann; Salvatore Chiantia
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

9.  Live Cell Characterization of DNA Aggregation Delivered through Lipofection.

Authors:  Stephen Mieruszynski; Candida Briggs; Michelle A Digman; Enrico Gratton; Mark R Jones
Journal:  Sci Rep       Date:  2015-05-27       Impact factor: 4.379

Review 10.  The neurobiology of LRRK2 and its role in the pathogenesis of Parkinson's disease.

Authors:  Hardy J Rideout; Leonidas Stefanis
Journal:  Neurochem Res       Date:  2013-06-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.